Product image of Normofundina Con Potasio (Magnesium Chloride Hexahydrate, Potassium Chloride, Sodium Chloride, Calcium Chloride Dihydrate, Glu) supplied by GNH India

Normofundina Con Potasio

Active Ingredient:
Magnesium Chloride Hexahydrate, Potassium Chloride, Sodium Chloride, Calcium Chloride Dihydrate, Glu
Origin:
EU

Normofundina Con Potasio (Magnesium Chloride Hexahydrate, Potassium Chloride, Sodium Chloride, Calcium Chloride Dihydrate, Glu)

Magnesium Chloride Hexahydrate, the active ingredient in Normofundina Con Potasio, is an electrolyte solution presented as an intravenous solution for intravenous use. It provides essential magnesium, potassium, sodium and calcium ions to correct electrolyte imbalances, support fluid volume, and maintain hydration in patients undergoing fluid resuscitation or suffering from hypokalemia, hypomagnesemia, or other electrolyte disturbances.

GNH India supplies Normofundina Con Potasio as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and clinics worldwide with consistent quality and regulatory compliance.

Manufacturer / TM Owner

B.Braun Medical, S.A.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Normofundina Con Potasio is an intravenous electrolyte solution used in the management of fluid and electrolyte disorders.

  • Electrolyte replacement: restores balanced levels of magnesium, potassium, sodium and calcium in patients with depleted electrolytes.
  • Fluid resuscitation: supplies necessary fluid volume to support circulation in patients with hypovolemia or shock.
  • Hypokalemia: provides potassium ions to raise serum potassium concentrations in individuals with low potassium levels.
  • Hypomagnesemia: delivers magnesium to correct low serum magnesium in patients at risk of cardiac or neuromuscular complications.

How It Works

  • Normofundina Con Potasio delivers magnesium, potassium, sodium, calcium and glucose directly into the extracellular compartment via intravenous infusion. The supplied ions are rapidly distributed, restoring osmotic balance, supporting cellular electrical activity, and expanding intravascular volume. By correcting specific electrolyte deficits, the solution helps normalize nerve conduction, muscle contraction, cardiac rhythm and overall fluid homeostasis.

Side Effects

Common Side Effects

  • Injection site pain: mild discomfort at the infusion site.
  • Mild hyperkalemia: slight increase in serum potassium.
  • Nausea: transient feeling of queasiness.
  • Headache: mild headache during or after infusion.

Serious or Rare Side Effects

  • Severe hyperkalemia: dangerous elevation of potassium that can affect cardiac rhythm.
  • Anaphylactic reaction: rare severe allergic response requiring immediate medical attention.
  • Cardiac arrhythmia: abnormal heart rhythm potentially linked to electrolyte shifts.

Precautions & Warnings

Before initiating therapy, consider the following precautions:

  • Assess electrolyte levels: measure serum magnesium, potassium, sodium and calcium before infusion.
  • Monitor cardiac function: observe ECG for arrhythmias during administration.
  • Adjust infusion rate: tailor speed to patient’s volume status and renal function.
  • Avoid in severe renal impairment: risk of electrolyte accumulation.
  • Store at ambient temperature: keep in original packaging, protect from light and moisture.

Avoid Interactions

Normofundina Con Potasio may interact with other medicines as follows:

Major Interactions (Avoid)

  • Concurrent use of potassium‑sparing diuretics: may cause dangerous hyperkalemia.
  • High‑dose magnesium supplements: risk of hypermagnesemia.
  • Calcium channel blockers: potential additive cardiovascular effects.

Moderate Interactions (Monitor Closely)

  • ACE inhibitors: monitor potassium levels closely.
  • Loop diuretics: may increase electrolyte loss, requiring dose adjustment.
  • NSAIDs: can affect renal function and electrolyte handling.

Frequently Asked Questions

Normofundina Con Potasio is an intravenous electrolyte solution used to replace lost electrolytes, restore fluid balance, and treat conditions such as hypokalemia, hypomagnesemia, and general fluid depletion in hospitalized patients.

Magnesium chloride hexahydrate dissociates after infusion, releasing magnesium ions that participate in enzymatic reactions, stabilize cell membranes, and help regulate cardiac and neuromuscular function while the accompanying potassium, sodium and calcium ions correct specific electrolyte deficits.

The dose is individualized and set by the prescribing clinician based on the patient’s electrolyte levels, fluid status, weight, and clinical condition. No fixed regimen is provided in the product information.

Safety data for use in pregnancy and lactation are limited. The product should be used only if the potential benefit justifies any potential risk to the fetus or infant, and decisions should be made in consultation with a healthcare professional.

Enquiries are submitted via the product page on gnhindia.com where you specify the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and import documentation.

Compared with standard balanced solutions such as Ringer's lactate, Normofundina Con Potasio contains higher concentrations of magnesium and potassium, making it suitable for patients needing targeted replenishment of these specific ions in addition to general fluid replacement.

Store the solution at ambient temperature, below 25 °C, in its original container. Protect it from direct sunlight, moisture and extreme temperature fluctuations to maintain stability and sterility.

The product is administered intravenously, typically via a controlled infusion pump or gravity drip. Administration rate and total volume are determined by the prescriber according to the patient’s clinical needs and monitoring parameters.

Serious risks include severe hyperkalemia or hypermagnesemia, which can lead to cardiac arrhythmias, and rare anaphylactic reactions. Continuous monitoring of electrolyte levels and cardiac status is essential during infusion.

Patients with known severe hyperkalemia, hypermagnesemia, or those with advanced renal failure where electrolyte clearance is markedly reduced should avoid this product unless closely monitored by a specialist.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Magnesium Chloride Hexahydrate, Potassium Chloride, Sodium Chloride, Calcium Chloride Dihydrate, Glu

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT